2006
DOI: 10.1161/01.hyp.0000210549.47167.db
|View full text |Cite
|
Sign up to set email alerts
|

Heart Failure and Left Ventricular Remodeling After Reperfused Acute Myocardial Infarction in Patients With Hypertension

Abstract: Abstract-In the thrombolytic era, hypertension has been shown to adversely affect the development of heart failure after acute myocardial infarction (AMI). We sought to examine the relation between antecedent hypertension and heart failure after mechanical reperfusion and to test the impact of postinfarction left ventricular remodeling on heart failure in hypertensive patients. A series of 953 patients (324 hypertensives) with AMI treated with successful primary percutaneous coronary intervention underwent a 5… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
20
1
2

Year Published

2007
2007
2013
2013

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 35 publications
(26 citation statements)
references
References 32 publications
3
20
1
2
Order By: Relevance
“…The prevalence of antecedent hypertension observed in this study is higher than previously reported, 6 likely because of the higher risk profile of AMI patients. Consistently, it matches the result observed in the Valsartan in Acute Myocardial Infarction (VALIANT) trial.…”
Section: Discussioncontrasting
confidence: 81%
See 4 more Smart Citations
“…The prevalence of antecedent hypertension observed in this study is higher than previously reported, 6 likely because of the higher risk profile of AMI patients. Consistently, it matches the result observed in the Valsartan in Acute Myocardial Infarction (VALIANT) trial.…”
Section: Discussioncontrasting
confidence: 81%
“…6,7 In this context some findings reported here may be of clinical interest. During the first 6 months after a reperfused AMI with LV systolic dysfunction there were no differences between patients with and without antecedent hypertension in LV remodelling processes, as assessed by the time course of serum products of collagen types I and III metabolism, plasma BNP and echocardiographic indices of LV geometry/function, respectively.…”
Section: Discussionsupporting
confidence: 56%
See 3 more Smart Citations